ACTINIUM PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 44.00 thousand shares for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2023-08-14
- ACTINIUM PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2023-06-30 was 43.00K shares.
- ACTINIUM PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2023-03-31 was 1.00K shares.
- ACTINIUM PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2021 was 1.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|
| 2023-06-30 | 43.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 44.00K shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 1.00K shares 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | 1.00 shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |